Machine learning

Neuron and antibodies
#AI / data analytics / healthtech / informatics #Antibodies #Antiverse #Drug discovery #Funding #Investment #Machine learning

AI company raises $3m to develop antibodies targeting GPCRs

Antiverse has successfully identified functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both displaying versatile binding profiles and nanomolar affinity.  The company has raised $3 million in funding, which will enable in-house development of the antibodies showing the highest affinity blocking function. The antibodies were identified using Antiverse’s proprietary… Read More

#News

#AI / data analytics / healthtech / informatics #Data science #Lab automation #Life science #Machine learning #Proteins #Proteomics #SLAS2023 #Therapeutics

Don’t miss the DDW Events podcast series for SLAS2023

Today marks the start of SLAS2023 in San Diego. Over the last week, DDW’s Megan Thomas has narrated five articles from the SLAS2023 supplement as part of the DDW Events podcast series. Episodes include: A Welcome to SLAS 2023 Acquiring deeper insights and acceleration with AI Connecting… Read More

#News

#AI / data analytics / healthtech / informatics #Cloud computing #High throughput screening #Lab automation #Machine learning #SLAS2023

How ML and automation are changing the future of protein therapeutics

Kristen Hopson, Vice President of Preclinical Discovery and Development at Generate Biomedicines, and Yue Liu, Associate Director, HTS at Generate Biomedicines, reflect on the impact of artificial intelligence (AI), machine learning (ML), cloud computing, and advances in laboratory automation and high-throughput screening (HTS) on life science research. Read More

#Exclusive Content

#Biomedicine #Cloud computing #High throughput screening #Lab automation #Life sciences #Machine learning #Proteins #Proteomics #SLAS2023 #Therapeutics

Podcast: ML and lab automation are changing protein therapeutics

Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March) DDW’s Megan Thomas narrates articles from the DDW SLAS2023 supplement as part of the DDW Events podcast series. This is episode four, How machine learning and lab automation are changing the… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Webinar: Choose the right drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Event: How to choose the most promising drug candidates

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Learn how to choose the best drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

How to choose the most promising drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry

Connected chemistry: How to choose the most promising drug candidates from your hit list

AI and machine learning (AI/ML) methods offer an alluring way to expedite the drug discovery process by delivering a large number of possible new candidates for any given therapeutic area. However, insight from medicinal chemists is still necessary to triage and prioritise the most promising molecules for synthesis, and progress… Read More

Webinar date:
Sponsored by Torx Software
#Webinars

microRNA
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Funding #Investment #Machine learning #Molecular Biology #RNA #Start-ups

$35 million to advance AI-driven RNA structure platform

Atomic AI, a biotechnology company fusing machine learning with structural biology to unlock RNA drug discovery, launched today with a $35 million Series A round.  The financing was led by Playground Global, with participation from 8VC, Factory HQ, Greylock, NotBoring, AME Cloud Ventures, and renowned angel investors… Read More

#Business & Investment #News #Start-up Zone

#AI #Deep learning #Drug discovery #Investment #Machine learning

€30 million raised to advance AI enabled drug discovery pipeline 

Aqemia has raised €30 million in a Series A funding round to further support its mission to massively scale drug discovery through a first-in-class technological platform combining quantum-inspired physics and machine learning.  The financing was led by Eurazeo and Bpifrance through its Large Venture fund, with the… Read More

#Business & Investment #News

#AI #Machine learning #Software

AI in R&D: From hot topic to practical application 

This paid-for advertorial by Benchling appeared in the DDW ebook – AI in drug discovery: How technology is driving innovation. By Ashoka Rajendra, Head of Development & Manufacturing Products at Benchling Artificial Intelligence (AI) is emblematic of the new era of modern biotech — data-driven, collaborative and ultimately,… Read More

#Business & Investment #Exclusive Content #Opinion #Trends & Analysis

#AI #AI / data analytics / healthtech / informatics #Machine learning #Pharma

Intelligent designs: How pharma researchers are using AI 

DDW Editor Reece Armstrong explores how AI is being utilised in the lab and what the technology can really do within pharma.  Artificial intelligence (AI), a branch of computer science encompassing machine learning and deep learning, and which technologies such as automation, natural language processing… Read More

#Business & Investment #Exclusive Content #Opinion #Trends & Analysis

#AI #Drug discovery #Machine learning #Oncology

The role of machine learning in cancer drug development

Throughout the continuum of drug development, from target discovery to patient selection, machine learning approaches are being adopted to reliably mine vast amounts of data and make predictions with higher accuracy Anita Ramanathan discusses how machine learning is currently used across different stages of cancer research.  Applying… Read More

#Cancer Research #Exclusive Content

#AI / data analytics / healthtech / informatics #Lab automation #Machine learning

AI in drug discovery eBook out now  

This 28-page DDW eBook, sponsored by Benchling, contains exclusive insight from industry experts on how technology is driving innovation.   Key topics include:   The benefits of AI in the lab   Precision medicine and AI   The next step in big… Read More

#News

#AI / data analytics / healthtech / informatics #Covid-19 #Machine learning #SLAS Europe

A different future is possible with the right data

Listen to this article on the DDW Podcast: Philip Gribbon is Head of Discovery Research at the Fraunhofer Institute for Translational Medicine and Pharmacology in Hamburg, Germany. Ahead of his participation in a Data Sharing panel at SLAS Europe 2022, Gribbon tells Megan Thomas about the importance and lasting… Read More

#Exclusive Content #Opinion #Trends & Analysis